Finasteride Tablet, Film Coated
Product Images NDC 50090-4697

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Finasteride (NDC 50090-4697). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Finasteride Figure 1 (Finasteride Fig.1)

The text is providing data on mean change from baseline with standard error for Finasteride at year 4 with sample sizes of 1438 and 1437.*

FDA Label Image

Finasteride-fig.2 (Finasteride Fig.2)

FDA Label Image

Finasteride Figure 2 (Finasteride Fig.3)

This appears to be a table showing the mean percent change from baseline with standard error (SE) for a placebo group and a group taking finasteride over a period of four years, with data collected annually. The baseline for the placebo group was 155 and for the finasteride group was 157. The table shows a decline in values over time for both groups, with finasteride showing a smaller decline compared to the placebo group.*

FDA Label Image

Finasteride Figure 4 (Finasteride Fig.4)

This appears to be a graph showing the percentage of people who experienced an event plotted against the number of years since randomization. The graph shows that at 25 years from randomization, 201 people experienced the event, and the percentage of people who experienced the event was 25%.*

FDA Label Image

Structutre (Finasteride Structure)

FDA Label Image

Label Image (Lbl500904697)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.